Mount Sinai Health System
Search
Profile image of Bruce E Sands
Video Visit Available
Accepting New Patients
  • Mount Sinai Doctors
  • Treats Adults

Bruce E Sands, MD

Gastroenterology

Clinical Focus

Education

MD, Boston University School of Medicine

Residency, Internal Medicine

Hospital of the University of Pennsylvania

Fellowship, Gastroenterology

Massachusetts General Hospital

Certifications

American Board of Internal Medicine

Awards

2010

Chair, Immunology, Microbiology & Inflammatory Bowel Disease Section

American Gastroenterological Association

2007

Chair, Clinical Research Alliance

Crohn's & Colitis Foundation of America

Fellow

American College of Gastroenterology

Fellow

American Gastroenterological Association

Research

Dr. Sands' research as a clinical investigator focuses on extending basic pathogenetic observations in the inflammatory bowel diseases--Crohn's disease and ulcerative colitis--to translational research and clinical trials.  I have been an active investigator in clinical trials of novel agents directed at specific pathophysiologic targets in IBD in all phases of study. His earliest clinical trial work was with infliximab, a chimeric monoclonal anti-tumor necrosis factor antibody that has revolutionized the treatment of Crohn's disease. Dr. Sands was among the first to report on the efficacy of infliximab in ulcerative colitis, later borne out in large randomized controlled trials. Dr. Sands was also overall principal investigator for a large randomized controlled trial of  infliximab in fistulizing Crohn's disease, the largest such study to date.  In addistion to his work in clinical trials, Dr. Sands's research has included extensive work in observational studies in IBD, including outcomes research and epidemiologic studies.  Most recently, he is the principal investigator of OSCCAR, the Ocean State Crohn's & Colitis Area Registry, a novel, prospective, population-based inception cohort of inflammatory bowel disease based in the state of Rhode Island.  The goals of this study are to 1) develope robust predictive models for outcomes in IBD, and 2) to elucidate the role of environmental risk factors in the onset of IBD.

 

 

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Patient Experience Star Ratings and Comments

The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.

Care Provider’s Explanation

Care Provider’s Concern

Likelihood to Recommend Care Provider

Dr. Sands is excellent physician and communicator.

Very good

Dr. Sands went above and beyond to ensure I felt heard and valued. He presented me with facts, options, and is professional opinion with grace and empathy.

Industry Relationships